The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Open accessAbstract
Infiltrating inflammatory cells are highly prevalent within the tumor microenvironment and mediate many processes associated with tumor progression; however, the contribution of specific populations remains unclear. For example, the nature and function of tumor-associated neutrophils (TANs) in the cancer microenvironment is largely unknown. The goal of this study was to provide a phenotypic and functional characterization of TANs in surgically resected lung cancer patients. We found that TANs constituted 5%-25% of cells isolated from the digested human lung tumors. Compared with blood neutrophils, TANs displayed an activated phenotype (CD62L(lo)CD54(hi)) with a distinct repertoire of chemokine receptors that included CCR5, CCR7, CXCR3, and CXCR4. TANs produced substantial quantities of the proinflammatory factors MCP-1, IL-8, MIP-1α, and IL-6, as well as the antiinflammatory IL-1R antagonist. Functionally, both TANs and neutrophils isolated from distant nonmalignant lung tissue were able to stimulate T cell proliferation and IFN-γ release. Cross-talk between TANs and activated T cells led to substantial upregulation of CD54, CD86, OX40L, and 4-1BBL costimulatory molecules on the neutrophil surface, which bolstered T cell proliferation in a positive-feedback loop. Together our results demonstrate that in the earliest stages of lung cancer, TANs are not immunosuppressive, but rather stimulate T cell responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822 · cited 1×
“Critical species-specific differences in both innate and adaptive immunity make assumptions of equivalence unwise (9), especially given recent studies that have shown that certain rodent models poorly replicate inflammatory diseases in humans (10).”
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Self-citationGenomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Nozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867
Kusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.989 · Cited by 850
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.010 · Cited by 850
A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1
Pillay, J., Kamp, V. M., van Hoffen, E., Visser, T., Tak, T., Lammers, J.-W., Ulfman, L. H., Leenen, L. P., Pickkers, P., & Koenderman, L. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57990 · Cited by 828
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549
Youn, J.-I., Collazo, M., Shalova, I. N., Biswas, S. K., & Gabrilovich, D. I. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311177 · Cited by 510
Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., & von der Maase, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9498 · Cited by 461
Gao, J.-L., Wynn, T. A., Chang, Y., Lee, E. J., Broxmeyer, H. E., Cooper, S., Tiffany, H. L., Westphal, H., Kwon-Chung, J., & Murphy, P. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.1959 · Cited by 441
Tumor associated macrophages and neutrophils in tumor progression
Galdiero, M. R., Garlanda, C., Jaillon, S., Marone, G., & Mantovani, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24260 · Cited by 440
Identification and manipulation of tumor associated macrophages in human cancers
Heusinkveld, M., & van der Burg, S. H. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-216 · Cited by 435
Suppression of T-cell functions by human granulocyte arginase
Munder, M. (2006) · Blood · doi:10.1182/blood-2006-11-010389 · Cited by 417
Neutrophils Promote Liver Metastasis via Mac-1–Mediated Interactions with Circulating Tumor Cells
Spicer, J. D., McDonald, B., Cools-Lartigue, J. J., Chow, S. C., Giannias, B., Kubes, P., & Ferri, L. E. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2393 · Cited by 401
Görgün, G. T., Whitehill, G., Anderson, J. L., Hideshima, T., Maguire, C., Laubach, J., Raje, N., Munshi, N. C., Richardson, P. G., & Anderson, K. C. (2013) · Blood · doi:10.1182/blood-2012-08-448548 · Cited by 393
On the dual roles and polarized phenotypes of neutrophils in tumor development and progression
Piccard, H., Muschel, R. J., & Opdenakker, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.06.004 · Cited by 373
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Mishalian, I., Bayuh, R., Levy, L., Zolotarov, L., Michaeli, J., & Fridlender, Z. G. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1476-9 · Cited by 356
Rao, H.-L., Chen, J.-W., Li, M., Xiao, Y.-B., Fu, J., Zeng, Y.-X., Cai, M.-Y., & Xie, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030806 · Cited by 327
Liu, C.-Y., Wang, Y.-M., Wang, C.-L., Feng, P.-H., Ko, H.-W., Liu, Y.-H., Wu, Y.-C., Chu, Y., Chung, F.-T., Kuo, C.-H., et al. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0634-0 · Cited by 313
Colombo, M. P., Ferrari, G., Stoppacciaro, A., Parenza, M., Rodolfo, M., Mavilio, F., & Parmiani, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.889 · Cited by 313
Jensen, T. O., Schmidt, H., Møller, H. J., Donskov, F., Høyer, M., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2012) · Cancer · doi:10.1002/cncr.26511 · Cited by 281
Trellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., Scherag, A., Hütte, J., Dominas, N., Lehnerdt, G. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25892 · Cited by 281
Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
Li, Y.-W., Qiu, S.-J., Fan, J., Zhou, J., Gao, Q., Xiao, Y.-S., & Xu, Y.-F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.044 · Cited by 268
Hartl, D., Krauss-Etschmann, S., Koller, B., Hordijk, P. L., Kuijpers, T. W., Hoffmann, F., Hector, A., Eber, E., Marcos, V., Bittmann, I., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8053 · Cited by 236
Photodynamic Therapy Enhancement of Antitumor Immunity Is Regulated by Neutrophils
Kousis, P. C., Henderson, B. W., Maier, P. G., & Gollnick, S. O. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1778 · Cited by 224
Lentzsch, S., Gries, M., Janz, M., Bargou, R., Dörken, B., & Mapara, M. Y. (2003) · Blood · doi:10.1182/blood-2002-08-2383 · Cited by 218
van Vliet, S. J., Gringhuis, S. I., Geijtenbeek, T. B. H., & van Kooyk, Y. (2006) · Nature Immunology · doi:10.1038/ni1390 · Cited by 216
Suttmann, H., Riemensberger, J., Bentien, G., Schmaltz, D., Stöckle, M., Jocham, D., Böhle, A., & Brandau, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1416 · Cited by 212
Circulating and tumor‐infiltrating myeloid cell subsets in patients with bladder cancer
Eruslanov, E., Neuberger, M., Daurkin, I., Perrin, G. Q., Algood, C., Dahm, P., Rosser, C., Vieweg, J., Gilbert, S. M., & Kusmartsev, S. (2012) · International Journal of Cancer · doi:10.1002/ijc.26123 · Cited by 205
Self-citationIFN-γ-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1
de Kleijn, S., Langereis, J. D., Leentjens, J., Kox, M., Netea, M. G., Koenderman, L., Ferwerda, G., Pickkers, P., & Hermans, P. W. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072249 · Cited by 203
Radsak, M., Iking‐Konert, C., Stegmaier, S., Andrassy, K., & Hänsch, G. M. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00140.x · Cited by 201
Caruso, R. A., Bellocco, R., Pagano, M., Bertoli, G., Rigoli, L., & Inferrera, C. (2002) · Modern Pathology · doi:10.1097/01.mp.0000020391.98998.6b · Cited by 194
Ilie, M., Hofman, V., Ortholan, C., Bonnetaud, C., Coëlle, C., Mouroux, J., & Hofman, P. (2012) · Cancer · doi:10.1002/cncr.26456 · Cited by 179
The paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances
Houghton, A. M. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11297 · Cited by 166
Fortunati, E., Kazemier, K. M., Grutters, J. C., Koenderman, L., & den Bosch, V. J. M. M. V. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03791.x · Cited by 161
Protumor and antitumor functions of neutrophil granulocytes
Brandau, S., Dumitru, C. A., & Lang, S. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0344-6 · Cited by 158
Potter, N., & Harding, C. V. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2538 · Cited by 158
Rapid fluorescence-based measurement of neutrophil migration in vitro
Frevert, C. W., Wong, V. A., Goodman, R. B., Goodwin, R., & Martin, T. R. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00016-7 · Cited by 155
Chacon, J. A., Wu, R. C. H., Sukhumalchandra, P., Molldrem, J. J., Sarnaik, A. A., Pilon‐Thomas, S., Weber, J. S., Hwu, P., & Radvanyi, L. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060031 · Cited by 149
Kobayashi, S. D., Voyich, J. M., Whitney, A. R., & DeLeo, F. R. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605289 · Cited by 148
Shao, Z., & Schwarz, H. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0510315 · Cited by 145
Hernandez-Chacon, J. A., Li, Y., Wu, R. C. H., Bernatchez, C., Wang, Y., Weber, J. S., Hwu, P., & Radvanyi, L. G. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318209e7ec · Cited by 141
Carus, A., Ladekarl, M. B., Hager, H., Pilegaard, H. K., Nielsen, P. S., & Donskov, F. N. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.03.003 · Cited by 128
Impact of Human Granulocyte and Monocyte Isolation Procedures on Functional Studies
Zhou, L., Somasundaram, R., Nederhof, R. F., Dijkstra, G. D. H., Faber, K. N., Peppelenbosch, M. P., & Fuhler, G. M. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05715-11 · Cited by 108
Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs)
Sica, A., Porta, C., Morlacchi, S., Banfi, S., Strauss, L., Rimoldi, M., Totaro, M. G., & Riboldi, E. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0091-6 · Cited by 101
Musiani, P., Allione, A., Modica, A., Lollini, P., Giovarelli, M., Cavallo, F., Belardelli, F., Forni, G., & Modesti, A. (1996) · PubMed · Cited by 101
CD200R signaling in tumor tolerance and inflammation: A tricky balance
Rygiel, T. P., & Meyaard, L. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.01.002 · Cited by 88
Giovarelli, M., Cappello, P., Forni, G., Salcedo, T. W., Moore, P. A., LeFleur, D. W., Nardelli, B., Carlo, E. D., Lollini, P., Ruben, S. M., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3200 · Cited by 86
Yoshimura, T., & Takahashi, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1942 · Cited by 69
Sandilands, G. P., McCrae, J., Hill, K., Perry, M., & Baxter, D. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02471.x · Cited by 65
Using macrophage activation to augment immunotherapy of established tumours
Fridlender, Z. G., Jassar, A. S., Mishalian, I., Wang, L.-C., Kapoor, V., Cheng, G. J., Sun, J., Singhal, S. K., Levy, L., & Albelda, S. Μ. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.93 · Cited by 64
Self-citationPoly's plea: membership to the club of APCs
Ashtekar, A. R., & Saha, B. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00235-7 · Cited by 56
Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways
Pignatti, P., Moscato, G., Casarini, S., Delmastro, M., Poppa, M., Brunetti, G., Pisati, P., & Balbi, B. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.048 · Cited by 51
Neutrophils and T cells: Bidirectional effects and functional interferences
Thewissen, M. M., Damoiseaux, J. G. M. C., van de Gaar, J., & Tervaert, J. W. C. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.07.006 · Cited by 46
Cited by
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Myeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Metadata
- Authors
- Eruslanov, E. B., Bhojnagarwala, P. S., Quatromoni, J. G., Stephen, T. L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W. W., Conejo-Garcia, J. R., Feldman, M., Albelda, S. M., & Singhal, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-11-10
- Volume
- 124
- Issue
- 12
- Pages
- 5466-5480
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2067931754
- Cited by
- 644
- References
- 66
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.